Riskpilot← Back to searchSign inGet full accessVITAL PHARMA AS
ASActiveOrg 989192744Jonsvannsveien 140, 7050 TrondheimWholesale of other food · NACE 4638Est. 20065 employeeswww.vitalpharma.no
Revenue 2025
NOK 9,3M
-8% vs 2024
EBITDA margin
0.2%
-96% vs 2024
Equity ratio
22.9%
Financial strength
Net profit 2025
NOK 3K
-99% vs 2024
| Revenue | NOK 9,3M | -8% |
| EBITDA | NOK 20K | -96% |
| Net profit | NOK 3K | -99% |
| Total assets | NOK 3,1M | +8% |
| Equity | NOK 720K | +0% |
| Employees | 5 | — |
Legal name
VITAL PHARMA AS
Org number
989192744
Legal form
Aksjeselskap
NACE code
4638 · Wholesale of other food
Founded
9. januar 2006
Share capital
NOK 105 000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Import og salg av helserelaterte produkter.
Address
Jonsvannsveien 140, 7050 Trondheim
Website
www.vitalpharma.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2 879 | 164 | 2 260 | 3 665 | 4 777 | 4 677 | 5 322 | 3 794 | 3 830 | 5 584 | 8 937 | 10 538 | 8 753 | 4 650 | 8 746 | 10 352 | 10 106 | 9 264 |
| Staff expenses | −2 012 | −1 569 | −1 383 | −715 | −1 106 | −1 551 | −2 759 | −2 546 | −2 438 | −3 197 | −4 213 | −4 357 | −1 251 | −1 540 | −3 845 | −4 104 | −3 616 | −3 856 |
| EBITDA | −519 | −2 066 | −986 | 1 384 | 2 048 | 702 | −68 | −1 345 | −441 | −50 | −458 | 75 | 601 | 340 | −154 | 1 284 | 468 | 20 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | −519 | −2 066 | −986 | 1 384 | 2 048 | 702 | −68 | −1 345 | −441 | −50 | −458 | 75 | 601 | 340 | −154 | 1 284 | 468 | 20 |
| Net financials | −4 | −15 | −2 | 1 | −107 | −93 | −79 | −78 | −72 | 564 | −12 | −16 | −17 | −18 | −27 | −13 | −15 | −17 |
| Profit before tax | −523 | −2 081 | −988 | 1 385 | 1 942 | 609 | −148 | −1 423 | −513 | 514 | −470 | 59 | 584 | 322 | −181 | 1 271 | 453 | 3 |
| Tax | −223 | −54 | −0 | −0 | 123 | 176 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −300 | −2 028 | −988 | 1 385 | 1 819 | 432 | −148 | −1 423 | −513 | 514 | −470 | 59 | 584 | 322 | −181 | 1 271 | 453 | 3 |
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1 706 | 503 | 415 | 1 447 | 2 659 | 2 675 | 2 907 | 1 180 | 1 086 | 1 743 | 1 709 | 807 | 838 | 1 239 | 1 139 | 2 455 | 2 900 | 3 143 |
| Equity | — | −1 577 | −2 565 | −1 180 | 1 016 | 1 448 | 1 300 | −123 | −635 | −121 | −592 | −532 | 52 | 374 | 193 | 1 464 | 717 | 720 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 437 | 347 | 275 | 145 | 30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 255 | 2 079 | 2 980 | 2 627 | 1 644 | 789 | 1 259 | 1 028 | 1 577 | 1 834 | 2 301 | 1 340 | 786 | 865 | 947 | 991 | 2 183 | 2 423 |
| Total debt | 1 255 | 2 079 | 2 980 | 2 627 | 1 644 | 1 227 | 1 606 | 1 303 | 1 722 | 1 864 | 2 301 | 1 340 | 786 | 865 | 947 | 991 | 2 183 | 2 423 |
EBITDA margin
0.2%
This company
15.8%
Market median
-99% vs market
20082025
Equity ratio
22.9%
This company
38.2%
Market median
-40% vs market
20082025
Return on equity
0.4%
This company
18.4%
Market median
-98% vs market
20082025
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20082025
Asset turnover
2.95×
This company
1.12×
Market median
+163% vs market
20082025
Debt / equity
3.37×
This company
0.62×
Market median
-444% vs market
20082025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-12-31
- Annual report 2008Filed via Brønnøysundsregistrene · Period 2008-01-01 – 2008-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
TS Deputy Member | Deputy Member | 2006 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2006 | — | — | |
| Deputy Chairman | 2006 | — | — | |
| Chairman | 2006 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Kteo As | Company | 33.3% | 33.3% | 2022 |
Kgl As | Company | 33.3% | 33.3% | 2022 |
Tel As | Company | 33.3% | 33.3% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Tel As
VITAL PHARMA AS Board members of VITAL PHARMA AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tove Sandsve | Deputy Member | 0 companies |
| Kim-Tore Engstad Olsen | Board of Directors | 0 companies |
| Trond Eivind Lund | Deputy Chairman | 0 companies |
| Kjell Gunnar Lund | Chairman | 0 companies |